View on Pubmed.gov 18028321 | View on doi.org 10.1111/j.1478-...
Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection.
- Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Abstract
BACKGROUND
Elevated serum hepatitis B virus (HBV) DNA increases the development of hepatocellular carcinoma (HCC). Rather than instantaneous DNA level, the duration of persistent HBV replication is more important in carcinogenesis. Nevertheless, most investigators evaluated the DNA level at study entry. We assessed the effects of persistently detectable serum HBV DNA on HCC recurrence.
PATIENTS AND METHODS
We included 230 consecutive patients undergoing curative resection between 2000 and 2006. Patients who had antiviral therapy (at diagnosis or during follow-up), fluctuating DNA (cut-off value: 100,000 copies/ml) or recurrence within 12 months of resection were excluded. Ultimately, 157 were enrolled: 89 (non-viraemia group) had consistently negative DNA (<100,000 copies/ml), while 68 (viraemia group) had consistently positive DNA (>100 000copies/ml). Serum DNA level, biochemical tests, alpha-foetoprotein (AFP) and liver dynamic computed tomography were obtained every 3 months after surgery.
RESULTS
There were no significant differences in age, gender, liver function, histology, AFP, tumour stages or follow-up duration between the two groups. During follow-up (median: 35 months), patients in the non-viraemia group had a lower 5-year cumulative recurrence rate (54.7%) than those in the viraemia group (72.9%; P=0.043). In multivariate analysis, sustained viraemia (P=0.041) increased recurrence independently.
CONCLUSIONS
Persistent viraemia increased recurrence independently after surgery. To prevent long-term recurrences, antiviral therapy should be initiated in those with detectable serum HBV DNA.
References
Cited by 130 citations (total)
Journal Article
The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma.
Electronic publication date October 14, 2011
Liang-He Yu [...] Shu-Qun Cheng et al.
Hepatocellular carcinoma (HCC) is a highly prevalent and lethal cancer worldwide; despite the curative treatment for HCC, the rate of...
Journal Article
Effects of long-term entecavir treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients.
Electronic publication date January 19, 2017
Takao Watanabe [...] Yoichi Hiasa et al.
BACKGROUND AND AIM
Entecavir is one of the most-used nucleoside analogues for the treatment of patients with chronic hepatitis B virus...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
- •
- •
- •